Partnering and Investment

CURRENT COLLABORATION PARTNERS

CellProtect Nordic Pharmaceuticals AB is currently involved in two collaborations:

  • Commercial partner of the 25 MSEK VINNOVA consortium “Cell Therapies”.
  • Collaboration with Hematology Centre, Karolinska University Hospital Huddinge for the conduction of Phase I/II trial in multiple myeloma patients.

PARTNERING OPPORTUNITIES

CPNP is particularly interested in partnerships with the following objectives:

  • continued clinical development of cell therapies.
  • commercialization of CellProtect (including health care providers and clinics).

Please contact the CEO on karin.mellstrom@cellprotect.com for more information.